WBTN vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

WBTN

39.2
AI Score
VS
PACS Wins

PACS

60.6
AI Score

Investment Advisor Scores

WBTN

39score
Recommendation
SELL

PACS

61score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric WBTN PACS Winner
Revenue 659.34M 2.85B PACS
Net Income -24.70M 157.06M PACS
Net Margin -3.7% 5.5% PACS
Operating Income -23.60M 229.37M PACS
ROE -2.1% 14.1% PACS
ROA -1.6% 2.8% PACS
Total Assets 1.59B 5.66B PACS
Cash 583.14M 164.45M WBTN
Current Ratio 2.63 0.91 WBTN

Relative Price Performance (Last 90 Days)

WBTN 1M: +5.2% · 3M: -6.7% PACS 1M: -2.6% · 3M: -7.8%

Current Technical Phase

WBTN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.0 · Price: $10.86

PACS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $41.03

Fundamentals Snapshot

Metric WBTN PACS
Market Cap — —
Forward P/E 43.4 15.1
Trailing P/E — 24.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.1%
EPS -2.63 1.71
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.